Laboratory Corp of America Holdi (NYSE: LH) has reported earnings for its fourth fiscal quarter (ending December 31) of $1.72 versus a loss $-1.97 for the same period a year ago — a decline of -187%. For the latest four quarters through December 31, E.P.S. were $8.89 versus $4.35 for the same period a year ago — an increase of 104%.
Recent Price Action
Laboratory Corp of America Holdi (NYSE: LH) stock closed at $247.74 on 2/6/25 after a slight decline of -0.9%. Moreover, trading volume in this decline was unusually high at 185% of normal. Relative to the market the stock has been strong over the last nine months and has risen 0.6% during the last week.
Current PriceTarget Research Rating
Laboratory has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Laboratory has a slightly negative Appreciation Score of 31 but a good Power Rating of 73, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment